Methods
This retrospective longitudinal multicenter study was designed as part of the Dysrhythmias in Patients With Congenital Heart Disease (DaNaRA) project (MEC-2012-482), which was approved by the local ethics committee in the Erasmus University Medical Center, Rotterdam. Informed consent was not obliged.
Study Population
Patients with CHD and at least 1 documented episode of AF observed during routine control at the outpatient clinic, hospitalization, or at the emergency room were derived from medical databases of the participating hospitals in the Netherlands, including Erasmus University Medical Center, Rotterdam; Amphia Hospital, Breda; Medisch Spectrum Twente, Enschede; VU Medical Center, Amsterdam; Haga Hospital, The Hague; Catharina Hospital, Eindhoven; and Center Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Data on demographics and clinical characteristics, including type of CHD, echocardiograms, cardiac surgery, prescribed antiarrhythmic drugs (AAD), outcome of cardioversion, and ablative therapy, such as endovascular catheter ablation for pulmonary vein isolation (ePVI), surgical pulmonary vein isolation (surPVI), transient ischemic attack (TIA), cerebrovascular accidents, and death, were retrieved from the patient medical records. PVI, either endovascular or surgical, was considered successful when isolation of all pulmonary veins was achieved. Regarding the type of CHD, we grouped the patients according to complete repair (aortic valve disease [AVD], atrial septal defect [ASD], atrioventricular septal defect, ventricular septal defect [VSD], patent ductus arteriosus, pulmonary stenosis, and cor triatrium), complex repair (coarctation of the aorta, Ebstein anomaly, pulmonary atresia with VSD, situs inversus, tetralogy of Fallot, transposition of the great arteries [TGA], congenitally corrected TGA [ccTGA]), and patients with a univentricular heart (UVH). Patients were followed until June 2014.
Analysis of the Rhythm Registrations
ECG and 24-hour Holter registrations were reviewed for episodes of AF or regular AT; all registrations were independently examined by 2 investigators. AF was defined as an irregular rhythm combined with a clear beat-to-beat variation in the morphology of atrial waves. We did not differentiate between a typical (counter) clockwise atrial flutter, intra-atrial reentry tachycardia, or ectopic atrial tachycardia, as differentiation between these types of AT cannot always be made based on the surface ECG only. 9 The time frame of progression from paroxysmal AF to (long-standing) persistent/permanent AF was defined as the moment of the initial AF episode until the moment of the persistent AF episode.
Statistical Analysis
Continuous variables were expressed as mean±SD or median and interquartile range (25% and 75%). Student's t test or ANOVA test was used to compare patient groups. Categorical data were denoted by percentages and compared with the McNemar test, χ 2 test, or Fisher exact test. Factors associated with the age of development of AF were estimated with the use of linear regression models. Kaplan-Meier curves were made to illustrate the risk of progression from paroxysmal to long-standing persistent/permanent AF.
A P value of <0.05 was considered statistically significant. Statistical analysis was performed with SPSS, version 21 (IBM, Armonk, NY).
Results

Study Population
A total of 199 CHD patients with documented AF episodes are outlined in Figure 1 . The study population consisted of 15 different CHD, including ASD (n=58), AVD (n=34), tetralogy of Fallot (n=21), TGA (n=17), UVH (n=16), VSD (n=12), coarctation of the aorta (n=9), patent ductus arteriosus (n=7), pulmonary stenosis (n=7), atrioventricular septal defect (n=4), ccTGA (n=4), Ebstein anomaly (n=4), pulmonary atresia with VSD (n=4), cor triatrium (n=1), and situs inversus (n=1). Corrective or palliative cardiac surgery was performed in 150 patients (75%) at a median age of 12 years; the median number of surgical procedures performed was 1 (0-6). Eighteen of them had the first documented AF episode 1 (0-3) year before the initial surgical procedure.
First Episode of Atrial Fibrillation
In the entire study population, the first episode of AF was documented at a mean age of 49±17 years. As demonstrated in Figure 1 , the age of AF onset was widespread in most of the various CHD groups. Yet, patients with more complex defects, such as TGA (35±7 years) and UVH (29±11 years), mainly developed AF before the age of 40 years which is significantly younger than patients with ASD (57±6 years, P<0.01), AVD (53±15 years, P<0.01), or VSD (54±18 years, P<0.01).
Echocardiographic findings <1 year before the first episode of AF were obtained in 94 patients (47%). Thirty-nine patients (41%) were known with a septal defect (ASD, n=9; VSD, n=9), severe valvular dysfunction (aortic, n=4; mitral, n=4; pulmonary, n=8; tricuspid, n=8), and severe ventricular dysfunction (n=5). In addition, 29 patients (31%) had at most a moderate dysfunction of a valve (aortic, n=5; pulmonary, n=5; mitral, n=7; tricuspid, n=7) and ventricle (n=14). Among the patients without an echocardiographic report, 14 patients (13%) underwent a surgical procedure in the year of the first AF episode ≤3 years later for either an ASD (n=5) or valve repair (mitral valve, n=1; tricuspid, n=4; and aortic, n=8). 
Coexistence of Atrial Tachyarrhythmia
WHAT IS KNOWN
• Patients with congenital heart defects have improved survival and are now getting older which is associated with an increased incidence of atrial fibrillation.
• Atrial tachyarrhythmias and atrial fibrillation may coexist more commonly in patients with congenital heart defects.
WHAT THE STUDY ADDS
• Compared to patients without congenital heart defects or with simple congenital heart defects, atrial fibrillation develops at a younger age in patients with complex congenital heart defects.
• Episodes of atrial fibrillation and atrial tachycardia frequently coexist in patients with congenital heart defects.
• Progression from paroxysmal to long-standing persistent/permanent atrial fibrillation occurs frequently and relatively fast after the initial episode of atrial fibrillation.
(upper panel) and a regular AT observed in a patient with PS who initially presented with AF and was treated with class II AAD (lower panel).
AF coexisted with regular AT in 65 patients (33%) with 11 different types of CHD (Figure 3 , upper panel). As illustrated in the lower panel of Figure 3 , regular AT was documented 3 (0-7) years before AF in 42 patients (65%); in the remaining 23 patients (35%), regular AT was observed only 4 (1-7) years after the initial episode of AF. Patients with AF after a documented episode of regular AT (n=42; 44±14 years) tended to develop AF at a younger age compared with patients with only AF (n=157; 50±17 years, P=0.05), also partially because of a relatively high number of patients with complex CHD (eg, TGA) and UVH with coexistence (P=0.09). surPVI 1 year after the initial procedure. Six patients underwent a pacemaker implantation followed by a His bundle ablation because of recurrent drug refractory AF episodes. Despite ablative therapy, episodes of AF were still found after a period of 5 (0-13) years in 5 of them (36%) and 1 patient developed a regular AT after surPVI.
Rhythm was evaluated in 197 patients after a follow-up period of 5 (2-11) years; 2 patients were lost to follow-up. At the end of the follow-up period, 21 patients (11%) had died at the age of 61±18 years (ASD: n=7, tetralogy of Fallot: n=6, AVD: n=3, TGA: n=2, ccTGA: n=1, cor triatrium: n=1, and UVH: n=1); only 7 (33%) of them were treated with AAD, ePVI, and surPVI. Causes of death were heart failure (n=11), (postoperative) infection (n=3), ventricular fibrillation (n=2), respiratory insufficiency (n=1), ventricular fibrillation after defibrillator threshold-testing during implantable cardioverter defibrillator implantation (n=1), or unknown (n=3). Twelve patients had AF before death. In the remaining 176 patients, the last ECG demonstrated AF in 69 patients (39%); the other patients had sinus rhythm (n=72, 41%), atrial ectopic rhythm (n=11, 6%), AT (n=1, 1%), or paced rhythm (n=24, 14%). AF was most often found in the patients with ASD (n=26; 51%), whereas AF was only observed in 1 UVH patient (7%).
Progression of Atrial Fibrillation
Progression of AF from paroxysmal to (long-standing) persistent/permanent AF over time was studied in a subgroup of 112 patients of whom at least a yearly ECG was available. As illustrated in Figure 6 , progression was observed in 29 patients (26%). Four patients were already known with persistent AF when presenting for the first time. AF progressed from paroxysmal to (long-standing) persistent/permanent AF after only 3 (1-7) years in 29 patients, despite therapy aimed at rhythm control after the initial AF episode (AAD: n=20, 69%; surPVI: n=3, 12%). In the 79 patients without progression to (long-standing) persistent/permanent AF, 77 (97%) were treated with AAD. Five patients (6%) also underwent an ePVI/surPVI.
Thromboembolic Complications of Atrial Fibrillation
Sixteen patients (8%) experienced a cerebrovascular event 14 (2-33) years before the initial AF episode (TIA, n=5 and stroke, n=11). In addition, AF was discovered in 3 patients when presenting with a stroke. Two of them were already using anticoagulant drugs including 1 patient who had a hemorrhagic stroke.
Furthermore, 9 patients (5%) had a cerebrovascular event 2 (1-6) years after the initial documented AF episode, including 6 TIA and 3 stroke. Five of them were using anticoagulant drugs; data regarding prescribed drugs were missing in 3 patients. Altogether, 26 patients experienced a cerebrovascular event including 2 patients who had a TIA and stroke.
Discussion
To our knowledge, this is the first study examining development of AF over time in a large cohort of patients with CHD. Onset of AF occurred at a relatively young age, particularly in patients with complex CHD (TGA and UVH). Coexistence of episodes of AF and regular AT occurred in a considerable number of patients (33%). Most of them initially presenting with regular AT; this occurred more frequently in patients with complex defects, such as TGA and UVH. Progression from paroxysmal to (long-standing) persistent AF was observed in patients with a variety of CHD, especially ASD, and occurred only 3 years after the initial documented AF episode. 
Development of (Postoperative) AF
Areas of intra-atrial conduction delay or dispersion in refractoriness perpetuate AF. [10] [11] [12] [13] Previous electrophysiological studies have demonstrated that multiple zones of intra-atrial conduction delay and increased dispersion in refractoriness are indeed present in patients with surgically corrected CHD. 14 Multiple or complex surgical procedures give rise to scarring with interposition of fibrotic tissue hampering intra-atrial conduction. Conduction abnormalities may be further aggravated by dilatation of the atria because of persisting pressure/ volume overload after cardiac surgery 15 or because of (longstanding) residual septal defects, valvular, or ventricular dysfunction as observed in our study population. Dilatation of the atria also promotes triggered activity, giving rise to premature beats. 16, 17 Thus, a high number of premature beats combined with large areas of conduction delay and local dispersion in refractoriness increase the likelihood for AF to occur in this patient group.
To date, observations on the mechanism underlying AF in CHD patients are rare. Mapping studies in patients without CHD have demonstrated that the mechanism underlying AF may be either focal activity giving rise to fibrillatory conduction or multiple, narrow, independently propagated fibrillatory waves. 18 Ectopic activity giving rise to fibrillatory conduction and hence AF on the surface ECG has been described in a patient with Fontan circulation and a TGA patient who had undergone an arterial switch procedure. 19 The origin of ectopic activity was found in respectively the right atrial septum and right atrial free wall, and AF was eliminated by encircling the area of focal activity in both patients. 19 
Aging and Atrial Fibrillation
Patients in our study with ASD, AVD, and VSD developed AF between the fifth and sixth decade. As demonstrated in the Rotterdam and Framingham Study, the incidence of AF in the general population starts to increase in the fifth decade. 20, 21 Thus, CHD patients with these defects developed AF in the same decade as subjects in the general population. However, patients with other defects, in particular UVH and TGA, frequently developed AF already in the third or fourth decade. It is therefore likely that development of AF in CHD patients is not only a result of aging.
Coexistence of AT and AF
Coexistence of AF with regular AT was found in 33% of our population. Kirsh et al 6 examined the relation between intraatrial reentry tachycardia and AF in patients with CHD who underwent electric cardioversion. They found that only 17 of 149 subjects had both atrial flutter and AF; there was no evidence for progression from atrial flutter to AF in these patients or vice versa. 6 Ghai et al 22 observed in a cohort of Fontan patients that development of atrial arrhythmias, including AF and regular AT, was related to a higher number of surgical procedures. Cardiac surgery results in atrial incisions and insertion of prosthetic materials and the postoperative (persisting) pressure/volume overload may further give rise to extensive atrial scarring. [23] [24] [25] These alterations facilitate development of macro reentrant tachycardia as the reentry wavelet can circulate around surgically inserted prosthetic materials, suture lines, and areas of scar tissue. Focal AT also frequently arise in patients with CHD as low voltage areas result in diminishing electric coupling thereby facilitating ectopic activity. Regular AT cause electric remodeling, consisting of shortening of atrial refractoriness and inverse rate adaptation, thereby facilitating development of AF. 26, 27 This may explain why regular AT preceded development of AF in a large proportion of our population. These findings suggest that catheter ablation of regular AT, which is nowadays an accepted treatment modality with a reported successful outcome of at least 70% in patients with CHD, could prevent or delay the development of AF in some CHD patients. 19, 28, 29 In some patients, episodes of regular AT were documented only after development of AF. It could simply be that episodes of AF and AT alternate in CHD patients, due to, for example, formation of a functional line of conduction block between the caval veins 30, 31 and that the first AF or first regular AT episode is just a matter of which tachycardia is by chance documented.
Recurring episodes of AF may also play an important role in the progression of paroxysmal to persisting AF. Twentysix percent of our population showed deterioration from paroxysms of AF to (long-standing) persistent/permanent AF. Progression to persistent or permanent AF has been reported up to 18% and 25% in patients without CHD after a follow-up period of 4 and 5 years, respectively. 32, 33 In patients without CHD, electric and structural remodeling both contribute to the persistence of AF, 34 which might be aggravated by chronic atrial stretch because of persistent pressure/volume overload. 35 However, at present, there are no data available on the relation between remodeling and progression from paroxysmal to (long-standing) persistent/permanent AF in CHD patients. Older age at the moment of first AF presentation may influence progression to (long-standing) persistent/permanent AF as patients with progression in the European Heart Survey tended to be older than those who did not. 36 In our study population, progression of paroxysmal to (long-standing) persistent/permanent AF was relatively often observed in patients with ASD; a group that presents with AF at a relative old age compared with the other groups.
Role of the Pulmonary Vein Area
Deal et al 37 reported on surgical treatment of atrial arrhythmias in patients with a Fontan correction. After palliative surgery combined with a Cox-Maze III procedure in 76 patients with AF, there were no recurrences observed. ePVI has been reported as well. 38 Likewise our study, ePVI was especially performed in patients with complete repaired defects, such as ASD and VSD. After a follow-up period of 4 years, 27% was successfully treated, which was comparable with patients without CHD (36%; P=0.46). In a study by Kirsh et al, 6 patients who underwent palliative surgery or with residual left ventricular valvular lesions intended to develop AF more frequently. A substantial part of our study population was uncorrected at the time of presentation or needed a reoperation for valvular regurgitation/stenosis or residual shunting. These data suggest that the posterior left atrial wall also plays a role in the development of AF in CHD patients, possibly because of remodeling after long-term volume and pressure overload.
Cerebrovascular Complications of Atrial Fibrillation
The total incidence of TIA/stroke in our population was 13%. However, a considerable number of cerebrovascular events occurred before the initial documented AF episode. We cannot exclude that these patients had asymptomatic AF episodes. In patients with lone AF without concomitant heart disease, there is a lower incidence of TIA/stroke compared with our study population. 39 Six percent had a TIA/stroke during a long-term follow-up period of 15 years. Hoffmann et al also demonstrated a higher risk of cerebrovascular accidents in CHD patients. A 10-to 100-fold higher risk to develop cerebrovascular accidents was found in the relative young CHD population, with and without atrial arrhythmias, compared with patients of the same age. 40 A higher cerebrovascular accident rate was associated with the absence of sinus rhythm and cyanotic heart disease. Therefore, other risk stratifications might be necessary to prevent cerebrovascular events not only in CHD patients with AF but also in CHD patients without AF.
Study Limitations
Because of the retrospective design of this multicenter study, data on exact surgical details or prescribed antiarrhythmic/anticoagulant drugs during the entire follow-up period were insufficient for some patients. Onset of AF was defined as the first documentation of an AF episode using available ECG or 24-hour Holter monitoring. Asymptomatic paroxysms of AF could therefore have been missed. In addition, differentiation between (longstanding) persistent or permanent AF could not always be made. Furthermore, because of the selection of patients with a yearly ECG to assess to progression of paroxysmal to long-standing persistent/permanent AF, the relative number of patients with progression might have been overestimated compared with patients encountered in daily practice. Patients in this study underwent the first surgical procedure at a relatively older age compared with newborn CHD patients nowadays.
Conclusions
Patients with CHD develop AF at a young age, particularly in patients with complex defects, and progress frequently from paroxysmal AF to (long-standing) persistent/permanent AF. Coexistence of episodes of AF and regular AT occurred in a considerable number of patients; most of them initially presented with regular AT. The findings of our study suggest that aggressive therapy and close follow-up of CHD patients with atrial tachyarrhythmias are justified. Early (ablative) therapy for regular AT could theoretically prevent development of AF and hence also reduce long-term complications, such as stroke.
